4.7 Article

Reduced TDP-43 Expression Improves Neuronal Activities in a Drosophila Model of Perry Syndrome

Journal

EBIOMEDICINE
Volume 21, Issue -, Pages 218-227

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ebiom.2017.06.002

Keywords

Dynactin; TDP-43; Axonal transport; Dopamine; Parkinsonian syndrome; Neurodegeneration

Funding

  1. MEXT in Japan [26293070, 15H04842]
  2. Health Labor Sciences Research Grant [201324123A]
  3. Otsuka Pharmaceutical
  4. [23111003]
  5. Grants-in-Aid for Scientific Research [26293070, 15H04842] Funding Source: KAKEN

Ask authors/readers for more resources

Parkinsonian Perry syndrome, involving mutations in the dynein motor component dynactin or p150(Glued), is characterized by TDP-43 pathology in affected brain regions, including the substantia nigra. However, the molecular relationship between p150(Glued) and TDP-43 is largely unknown. Here, we report that a reduction in TDP-43 protein levels alleviates the synaptic defects of neurons expressing the Perry mutant p150(G50R) in Drosophila. Dopaminergic expression of p150(G50R), which decreases dopamine release, disrupts motor ability and reduces the lifespan of Drosophila. p150(G50R) expression also causes aggregation of dense core vesicles (DCVs), which contain monoamines and neuropeptides, and disrupts the axonal flow of DCVs, thus decreasing synaptic strength. The above phenotypes associated with Perry syndrome are improved by the removal of a copy of Drosophila TDP-43 TBPH, thus suggesting that the stagnation of axonal transport by dynactin mutations promotes TDP-43 aggregation and interferes with the dynamics of DCVs and synaptic activities. (C) 2017 The Author(s). Published by Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available